Firm Represents Facet Biotech Corporation in Unsolicited Acquisition Proposal by Biogen Idec Inc.
Simpson Thacher is representing Facet Biotech Corporation in connection with the unsolicited proposal made by Biogen Idec Inc. to acquire all outstanding shares of Facet Biotech. Facet Biotech is a biotechnology company which launched in December 2008 as a spin-off from PDL BioPharma, Inc.
The Simpson Thacher team includes: Rob Spatt, Rich Capelouto, Kirsten Jensen, Robert Bartlett, Jared Grauer and Grace Park.